Caricamento...
Ocriplasmin for Treatment of Vitreomacular Traction: An Update
Pharmacologic vitreolysis with ocriplasmin, a 27 kilodalton serine protease, is an effective nonsurgical treatment option for vitreomacular traction (VMT). Data from phase III clinical studies, including the Microplasmin for Intravitreal Injection—Traction Release without Surgical Treatment (MIVI-TR...
Salvato in:
| Pubblicato in: | Ophthalmol Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Healthcare
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5125123/ https://ncbi.nlm.nih.gov/pubmed/27619226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-016-0062-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|